MannKind Corp. (MNKD)
3.09
+0.05
(+1.64%)
USD |
NASDAQ |
Oct 19, 16:00
3.09
0.00 (0.00%)
Pre-Market: 09:09
MannKind Market Cap : 957.63M for Oct. 19, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 19, 2026 | 957.63M |
| October 16, 2026 | 942.13M |
| October 15, 2026 | 988.62M |
| October 14, 2026 | 935.93M |
| October 13, 2026 | 945.23M |
| October 12, 2026 | 970.02M |
| October 09, 2026 | 1.020B |
| October 08, 2026 | 1.060B |
| October 07, 2026 | 1.069B |
| October 06, 2026 | 1.150B |
| October 05, 2026 | 1.184B |
| October 02, 2026 | 1.178B |
| October 01, 2026 | 1.224B |
| September 30, 2026 | 1.209B |
| September 29, 2026 | 1.035B |
| September 28, 2026 | 1.038B |
| September 25, 2026 | 1.035B |
| September 24, 2026 | 1.020B |
| September 23, 2026 | 1.035B |
| September 22, 2026 | 1.082B |
| September 21, 2026 | 1.085B |
| September 18, 2026 | 1.097B |
| September 17, 2026 | 1.109B |
| September 16, 2026 | 1.100B |
| September 15, 2026 | 1.103B |
| Date | Value |
|---|---|
| September 14, 2026 | 1.162B |
| September 11, 2026 | 1.162B |
| September 10, 2026 | 1.175B |
| September 09, 2026 | 1.221B |
| September 08, 2026 | 1.289B |
| September 04, 2026 | 1.258B |
| September 03, 2026 | 1.227B |
| September 02, 2026 | 1.252B |
| September 01, 2026 | 1.233B |
| August 31, 2026 | 1.243B |
| August 28, 2026 | 1.224B |
| August 27, 2026 | 1.258B |
| August 26, 2026 | 1.268B |
| August 25, 2026 | 1.289B |
| August 24, 2026 | 1.261B |
| August 21, 2026 | 1.286B |
| August 20, 2026 | 1.320B |
| August 19, 2026 | 1.362B |
| August 18, 2026 | 1.261B |
| August 17, 2026 | 1.209B |
| August 14, 2026 | 1.193B |
| August 13, 2026 | 1.156B |
| August 12, 2026 | 1.193B |
| August 11, 2026 | 1.190B |
| August 10, 2026 | 1.218B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| United Therapeutics Corp. | 23.18B |
| ACADIA Pharmaceuticals, Inc. | 3.408B |
| Gilead Sciences, Inc. | 189.96B |
| Vertex Pharmaceuticals, Inc. | 127.17B |
| Ocugen, Inc. | 266.93M |
Market Cap Related Metrics
| PS Ratio | 2.426 |
| Price | 3.09 |
| Earnings Yield | -4.59% |
| Operating PE Ratio | 71.91 |